Lavipharm SA
XBER:BXA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lavipharm SA
XBER:BXA
|
GR |
|
S
|
SRM Entertainment Inc
NASDAQ:SRM
|
US |
|
E
|
Edil San Felice SpA Societa Benefit
MIL:ESF
|
IT |
Wall St Price Targets
BXA Price Targets Summary
Lavipharm SA
According to Wall Street analysts, the average 1-year price target for BXA is 0.617 EUR with a low forecast of 0.611 EUR and a high forecast of 0.635 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BXA's stock price target?
Price Target
0.617
EUR
According to Wall Street analysts, the average 1-year price target for BXA is 0.617 EUR with a low forecast of 0.611 EUR and a high forecast of 0.635 EUR.
What is the Revenue forecast for Lavipharm SA?
Projected CAGR
37%
Over the last 14 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 3 years is 37%.
What is the Gross Profit forecast for Lavipharm SA?
Projected CAGR
38%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is 38%.
What is the Operating Income forecast for Lavipharm SA?
Projected CAGR
62%
The compound annual growth rate for Operating Income over the next 3 years is 62%.
What is the Pre-Tax Income forecast for Lavipharm SA?
Projected CAGR
71%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 71%.
What is the Net Income forecast for Lavipharm SA?
Projected CAGR
70%
The compound annual growth rate for Net Income over the next 3 years is 70%.
